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Abstract
Curcumin has gained immense importance for its vast therapeutic and prophylactic applications. Contrary to this, our study
reveals that it regulates the defense pathways of Salmonella enterica serovar Typhimurium (S. Typhimurium) to enhance its
pathogenicity. In a murine model of typhoid fever, we observed higher bacterial load in Peyer’s patches, mesenteric lymph
node, spleen and liver, when infected with curcumin-treated Salmonella. Curcumin increased the resistance of S.
Typhimurium against antimicrobial agents like antimicrobial peptides, reactive oxygen and nitrogen species. This increased
tolerance might be attributed to the up-regulation of genes involved in resistance against antimicrobial peptides - pmrD
and pmrHFIJKLM and genes with antioxidant function - mntH, sodA and sitA. We implicate that iron chelation property of
curcumin have a role in regulating mntH and sitA. Interestingly, we see that the curcumin-mediated modulation of pmr
genes is through the PhoPQ regulatory system. Curcumin downregulates SPI1 genes, required for entry into epithelial cells
and upregulates SPI2 genes required to intracellular survival. Since it is known that the SPI1 and SPI2 system can be
regulated by the PhoPQ system, this common regulator could explain curcumin’s mode of action. This data urges us to
rethink the indiscriminate use of curcumin especially during Salmonella outbreaks.
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Introduction
In the last few years, curcumin has been widely used as an
herbal medicine [1,2]. Curcumin’s anti-bacterial activity in vitro
(against S. aureus, E.coli, S. lutea) has been attributed to its
phototoxic effect which produces H2O2, a toxic moiety for the
bacteria [3]. Same study reported that Salmonella enterica serovar
Typhimurium (S. Typhimurium) is susceptible but more resistant
to curcumin than S. aureus [3]. In B. subtilis, curcumin inhibits FtsZ
assembly dynamics by perturbing its GTPase activity [4]. It affects
the growth of H. pylori by inhibiting shikimate dehydrogenase, a
vital enzyme [5]. However, curcumin protects S. Typhimurium
TA1535/pSK1002 and E. coli K-12 strains by inhibiting SOS
induction and mutagenesis by UV light [6]. Curcumin also confers
resistance to E. coli, B. megaterium, and B. pumilus against the
inactivation of DNA, induced by gamma radiation [7]. The
knowledge of the effect of curcumin on pathogenicity of bacteria is
still in its infancy. In our work, we have addressed the role of
curcumin on pathogenicity of S. Typhimurium, a Gram-negative
facultative intracellular pathogen that causes systemic disease in
mice similar to the typhoid fever caused by serovar Typhi in
humans. S. Typhimurium is an important causative agent of
gastroenteritis in humans. The pathogenicity of S. Typhimurium is
largely dependent on its ability to evade and resist host innate
factors like antimicrobial peptides (AMPs), reactive oxygen (ROS)
and nitrogen species (RNI) [8,9,10,11,12] encountered during its
pathogenic life cycle. Presence of scavengers [13], antioxidant
enzymes [13], iron and manganese transport systems [14], LPS
modification systems [15], proteases, DNA repair systems [13] etc.
help the bacteria to protect themselves from the innate immune
factors of the host. S. Typhimurium have acquired Salmonella
Pathogenicity Island 1 (SPI1) and Salmonella Pathogenicity Island 2
(SPI2) that play an important role in the entry and survival of
bacteria inside the host cells, respectively [16].
In the following study, we demonstrate that curcumin enhances
the pathogenicity of S. Typhimurium in murine typhoid model.
We have attempted to delineate the pathway for the same. We
show that curcumin increases the resistance of S. Typhimurium
against the antimicrobial defenses viz. AMPs and oxidative stress,
exerted by the host. We further implicate that curcumin modulate
the expression of antioxidant genes through its iron chelation
property and SPI2 and pmr (LPS modification) genes through
PhoPQ two component system.
Materials and Methods
Bacterial strains, media and growth conditions
S. Typhimurium strain 12023 was used as wild-type (WT). WT,
WT with GFP (pFPV25.1) phoP
-(phoPQ mutant, CS015 [17]) (Kind
gift from Prof. M. Hensel, Institut fu ˝r Klinische Mikrobiologie,
Germany) and DsitA, generated in this study [18] were grown at
37uC in Luria broth (LB) containing 50 mg/ml nalidixic acid,
ampicillin, 20 mg/ml chloramphenicol and 50 mg/ml kanamycin
respectively. Curcumin (20 mM; Sigma), ferric chloride (32 mg/ml)
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required. Alternatively, the bacteria were also sub-cultured and
grown in F-media [19] for observing growth pattern.
Construction of sitA deletion mutant in S. Typhimurium
One step inactivation strategy described by Datsenko and
Wanner [18] was used. Briefly, S. Typhimurium strain carrying a
red helper plasmid (pKD46) were grown in LB with 50 mg/ml
ampicillin and 10 mM L-arabinose at 30uCt oa nO D 600 nm of
0.3–0.4. The electrocompetent cells were prepared by harvesting
the cells and then washing two times with sterile MilliQ water and
then with ice-cold 10% (v/v) glycerol. The PCR product
containing the kanamycin-resistance gene (from plasmid pKD4)
flanked by sequences upstream and downstream of sitA was
electroporated into electrocompetent cells. The knockout was
selected for kanamycin resistance and confirmed by PCR using the
confirmatory primers. The knockout obtained was non-polar.
Cloning of sitA gene in DsitA
The sitA gene was amplified using the cloning primers
(Supplementary table S1) and S. Typhimurium genomic DNA.
The amplified product was digested with BamHI and HindIII.
The digested product was purified and ligated with the predigested
pQE60 plasmid. The product was transformed into competent
E.coli cells and positive colonies were selected. Plasmid was isolated
from the positive clone and transformed into DsitA strain to obtain
the complement.
Construction of lacZ transcriptional fusions and b-
galactosidase assay
LacZ transcriptional fusions to mntH, sitA, sodA, and hilA
promoters were constructed as described previously [20] using
primers listed in supplementary table S1. pmrD, pmrHFIJKLM
(pmrHM) and spiC lacZ construct were kindly provided by Vidya
Negi and Priyanka Das (our lab). Transcriptional activity of each
gene was determined by performing b-galactosidase assay as
described previously [21].
Eukaryotic cell lines and growth conditions
RAW 264.7 cells were a kind gift from Prof. Anjali Karande
(Department of Biochemistry, IISc, Bangalore). Intestine 407 and
Caco-2 cells were kind gift from Dr. Patole (National Center for
Cell Science, Pune). BMDM were isolated from NRAMP1
+/+
mice (SWISS ALBINO) as described previously [20]. The cells
were grown in Dulbecco’s Modified Minimum Essential Medium
supplemented with 10% fetal bovine serum and maintained at
37uC and 5% CO2. For Caco-2 cells, 1% non-essential amino
acids was added to the medium.
Intracellular survival assay
The gentamicin protection assay was performed as described
previously [8].
Immunoblot
Curcumin treated and untreated bacteria were subcultured in
F-media (pH 5). Bacteria were pelleted at different time points and
lysed in SDS lysis buffer. Equal amount of protein was processed
for immunoblotting using anti-SseB antibody (a kind gift from
Prof. Michel Hensel).
H2O2 and NO
. tolerance assay
H2O2 and NO
. tolerance tests were done as described by
Buchmeier et al. [22] and Chakravortty et al. [23] respectively, with
some modifications. Briefly, overnight cultures of the wild type S.
Typhimurium grown under different conditions were diluted to
10
5 CFU in F-media (pH 5) and incubated with 1 mM H2O2 or
NaNO2 at 37uC and 180 rpm for 4 h. NaNO2 (NaNO2, Sigma-
Aldrich) and hydrogen peroxide (30% H2O2, Qualigens) solutions
were prepared freshly. Serial dilutions were made and plated onto
LB agar plates for the enumeration of surviving bacteria.
Antimicrobial peptide sensitivity assay
The assay was done as described by Fields et al. [24], with some
modifications. Bacteria, in the exponential phase (3 h incubation
at 37uC, 180 rpm, after 1:33 dilution of overnight culture in LB)
were taken for the assay. Bacteria (2–5610
5 for CFU analysis and
5–7.5610
6 for flow cytometry) were diluted in 0.5% tryptone-
0.5% sodium chloride solution and incubated with AMPs
[polymyxin B, 1 mg/ml (for CFU analysis), 0.5 mg/ml (Flow
cytometry) and protamine, 50 mg/ml (for CFU analysis), 30 mg/ml
(Flow cytometry)] at 37uC and 180 rpm. After 1 h, the samples
were either plated on LB agar for the enumeration of surviving
bacteria or were incubated with 1 mg/ml of bis-(1,3-dibutylbarbi-
turic acid)-trimethine oxonol [DiBAC4(3); Invitrogen] for 10 min
followed by 2 washes with PBS. The DiBAC4 (3) treated samples
were further analysed in FACS scanner (BD Biosciences) to test for
the change in membrane permeability upon AMP treatment.
Bacterial RNA extraction and RT-PCR analysis
RNA was isolated from the log phase bacteria grown in LB with
and without curcumin. cDNA was prepared from the bacterial
RNA using a reverse transcription system (Fermentas). cDNA was
amplified (35 cycles or 25 cycles for 16S rRNA) using primers
(supplementary Table S1) that amplify the intergenic region of the
specific genes.
Mice experiment
4–6-weeks-old BALB/c mice (obtained from Central Animal
Facility, Indian Institute of Science, Bangalore, India) were
maintained under specific-pathogen-free conditions. All the
procedures with animals were carried out in accordance with
approved protocols of Indian Institute of Science, Bangalore. Mice
were infected intra-gastrically or intra-peritoneally with 10
7 or 10
3
CFU of S. Typhimurium respectively. 3 days after infection, liver,
spleen, mesenteric lymph nodes (MLN), Peyer’s patches (PP) and
kidney were isolated under aseptic conditions, weighed and
homogenized in a tissue homogenizer. The homogenate was
plated at different dilutions to get CFU per gram weight of organ.
For invasion assay, the mice were sacrificed 1 h post-infection.
PP were isolated aseptically, weighed, homogenized and plated at
different dilutions to determine the CFU.
Mucus sensitivity test
Mucus was recovered from the small intestine of the BALB/c
mice and diluted (2 times) with PBS to reduce the viscosity. The
suspension was then centrifuged at 1000 xg for 5 min to settle the
cellular debris. 10
7 bacteria from overnight culture were incubated
in mucus under shaking condition (180 rpm) at 37uC. After 1 h,
the suspensions were plated onto Salmonella Shigella-agar to
determine the amount of surviving bacteria per milligram of the
mucus protein.
Statistical analysis
Each experiment was performed in triplicate and repeated a
minimum of 3 times. Data are shown as means 6 SE. Student’s
t-test or Mann Whitney U test were used for data analysis. All the
Curcumin and Salmonella
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Prism (version 5) softwares. Wherever applicable, P value #0.05
was considered as statistically significant.
Results
Presence of curcumin during growth of S. Typhimurium
increases its rate of proliferation
The concentration of curcumin was fixed at 20 mM based on
the MTT assay for eukaryotic cells and growth curve for bacterial
cells (Supplementary Figure S1, Materials and Methods S1). We
first assessed the effect of curcumin on pathogenicity of S.
Typhimurium by intracellular survival assay in macrophages and
epithelial cells. The fold-proliferation, from 2 h to 16 h post
infection, of S. Typhimurium grown in the presence of curcumin
(curcumin-treated) was 2–3 fold higher compared to that of the
untreated (Figure 1) in RAW 264.7, Intestine 407 and Caco-2
cells. These results suggest that curcumin treatment aids survival of
S. Typhimurium inside the host cells.
BALB/c mice infected intragastrically or intraperitoneally with
curcumin-treated or untreated S. Typhimurium were either
monitored for survival or dissected 3 days post infection to analyse
the bacterial burden in PP, MLN, spleen and liver. The mice
infected with curcumin treated S. Typhimurium had significantly
more bacterial burden in the organs tested (Figure 2A) and showed
lower survival rate (Figure 2B). The cecum weight (a hallmark of
salmonellosis) [25] of the mice infected (intragastrically) with
curcumin-treated S. Typhimurium was significantly less than that
of the mice infected with untreated S. Typhimurium (Figure 2A).
These observations strongly show that curcumin increases the
pathogenicity of S. Typhimurium.
Curcumin treatment altered the expression of SPI2 genes
of S. Typhimurium
Inside the host cell, S. Typhimurium exists in a compartment
known as Salmonella containing vacuole (SCV) [26]. SCV has pH
of 5, low Mg
2+ concentration, low phosphate concentration, high
K
+ concentration, and limited amino acid availability. F-medium
mimics to some extent the SCV environment [27]. To test
whether curcumin treatment gives any growth advantage to S.
Typhimurium under the stringent conditions of SCV, the growth
pattern of curcumin-treated bacteria was assessed in F-media.
There was no significant difference in the growth pattern of
curcumin-treated and untreated S. Typhimurium in F-media
(supplementary Figure S2), implying that curcumin does not
increase the proliferation of S. Typhimurium in SCV but might be
increasing its resistance against the host antimicrobial agents.
To defend itself from the host antimicrobial agents, S.
Typhimurium uses SPI2 effector proteins [27,28]. SPI2 genes
play an important role in the intracellular survival of bacteria,
especially in macrophages [23,28] by preventing the fusion of the
NADPH oxidase containing vesicles with the SCV [23,29,30].
SpiC, is a SPI2 protein that is necessary for the translocation of
SPI2 effectors into infected macrophages [31] and preventing the
fusion of SCV with endosome/lysosome [32]. Inside the host,
curcumin-treated bacteria survive better than the untreated ones.
So the regulation of SPI2 genes, if any, by curcumin was assessed
by reporter assay and western blotting. The promoter activity of
spiC was examined in curcumin treated and untreated bacteria,
grown in F media or isolated from RAW 264.7 cells. For this S.
Typhimurium harboring a spiC-lacZ construct (spiC promoter
cloned upstream of promoterless lacZ gene in pHG86 plasmid)
was used. The b-galactosidase assay was performed to check for
the change in promoter activity, if any. The increased b-
galactosidase activity in curcumin treated cells indicates that
curcumin increased the promoter activity of spiC at early time
points (upto 4–5 h) after which the activity remained similar to
that of the untreated bacteria (Figure 3A). Immunoblot for SseB, a
SPI2 encoded translocon protein, (for bacteria grown in F-media)
also reflected that curcumin increases SPI2 expression upto 4–5 h
(Figure 3A). As PhoPQ regulates SPI2 genes, it was speculated that
curcumin acts via PhoPQ. When phoP
- strain was used, there was
no difference in the activity of SPI2 gene (spiC) on curcumin
treatment, as assessed by b-galactosidase assay (Figure 3A). Also,
the intracellular proliferation of curcumin treated and untreated
phoP
- strain was similar (Figure 3B) indicating that curcumin might
be regulating SPI2 gene through PhoPQ. Thus, the increased
proliferation of curcumin-treated bacteria in macrophages could at
least be partially attributed to the up-regulation of SPI2 genes (at
least sseB and spiC) by curcumin.
Figure 1. Fold proliferation (2 h to 16 h) of S. Typhimurium. The
cells (RAW 264.7, Intestine 407 & Caco-2) infected with solvent (S),
curcumin (C, 20 mM) treated or untreated (UT) S. Typhimurium were
lysed at 2 h & 16 h post infection and fold replication of the bacteria
was calculated. *** P,0.001.
doi:10.1371/journal.pone.0011511.g001
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Typhimurium against ROS and RNI by regulating mntH
and sitA
Phagocytes exhibit their antimicrobial activity through the
production of ROS and RNI. The abilities of curcumin treated
and untreated bacteria to protect themselves from the cell
damaging intermediates, ROS (H2O2) and RNI (NO
.)w e r e
compared. NaNO2 protonates into HNO2, which rapidly
dismutates to produce several nitrite species including NO
.
[33]. The toxicity of NaNO2 solution is maximum in pH 4.4–5.5
range [34]. At low pH, H2O2 is quite stable and toxic. Survival of
the bacteria was evaluated in the presence of either 1 mM H2O2
or NaNO2 at pH 5. Curcumin treated S. Typhimurium showed
2–3 fold higher survival in the presence of H2O2 and NO
. as
Figure 2. Curcumin treated S. Typhimurium showed enhanced virulence in murine model of typhoid fever. A. Bacterial load in different
organs of the mice infected with solvent (S) curcumin (C, 20 mM) treated or untreated (UT) S. Typhimurium. 3-days post-infection, different organs of
infected mice were aseptically isolated, weighed, homogenized and plated to get the CFU/gm. Cecum weight was plotted for mice infected
intragastrically. B. Survival of mice after infection with either curcumin treated or untreated S. Typhimurium. ** 0.001#P,0.01 and * 0.01#P,0.05.
doi:10.1371/journal.pone.0011511.g002
Figure 3. Modulation of SPI2 genes by curcumin. A. Promoter assay for spiC gene using a reporter strain (WT harbouring lacZ fusion of spiC
promoter in pHG86 plasmid) and immunoblot for SseB protein. b-galactosidase assay was done at different time points for bacteria, subcultured
(1:33) from overnight culture in F-media (pH 5) or isolated from RAW 264.7 cells. B. Fold proliferation of WT and phoP
- S. Typhimurium. RAW 264.7
infected with curcumin (C, 20 mM) treated or untreated (UT) S. Typhimurium were lysed after 2 h & 16 h and fold replication of the bacteria was
calculated.
doi:10.1371/journal.pone.0011511.g003
Curcumin and Salmonella
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respectively).
MntH and SitABCD, iron and manganese transport systems are
required for the resistance against H2O2 and virulence of S.
Typhimurium [35,36,37] especially in NRAMP
+/+ mice [38].
Manganese is required for the catalysis of enzymes like superoxide
dismutase (SodA) [37], involved in resistance to the early oxygen-
dependent microbicidal mechanisms of phagocytes [39]. The
regulation of sitA, mntH and sodA by curcumin was determined by
promoter assay. Promoters of respective genes were cloned
upstream of the promoterless lacZ gene in pHG86 plasmid and
the b-galactosidase assay was carried out to determine the change
in promoter activity on curcumin treatment. Curcumin increased
the promoter activity of these genes (Figure 4C). In addition,
curcumin treatment did not alter the resistance of the DsitA strain
against H2O2 and NO
. (Figure 4D & E) implicating that curcumin
increases resistance of the bacteria against oxidative stress by
regulating the expression of sitA and possibly mntH. As compared
to untreated DsitA the fold proliferation of curcumin treated DsitA
was high in RAW 264.7 (Figure 4F) cells but was indifferent in
NRAMP
+/+ BMDM (Figure 4G). The complement of DsitA strain
behaved similar to wildtype. However, curcumin treated and
untreated complement bacteria behaved similarly (Figure 4G) as
the sitA gene was cloned without the promoter sequence.
Curcumin treated phoP
- bacteria showed higher fold proliferation
in NRAMP
+/+ cells indicating that curcumin also acts on
pathways other than PhoPQ (may be sitA, mntH and sodA)t o
modulate intracellular survival of the bacteria in NRAMP
+/+ cells.
This suggests that the enhanced proliferation of curcumin treated
bacteria in RAW 264.7 cells is not through the regulation of sitA.
However, the regulation of sitA by curcumin may play a role on
intracellular proliferation of bacteria in NRAMP
+/+ host cells.
The iron binding property of curcumin has been implicated to
play a role in the treatment of cancer and neurodegenerative
disorders [40,41,42]. When tested, we found that iron chelation by
curcumin had a role in partially protecting S. Typhi-
murium against H2O2 and NO
. toxicity. Supplementation of iron
(32 mg/ml of FeCl3 or 20 mM FeSO4) in the growth media caused
reversal of the phenomena observed in the presence of curcumin
(Figure 4 A–C) implicating that iron chelating property of
curcumin might regulate the antioxidant genes (sitA and mntH)
and improve resistance against oxidative stress.
Increased expression of pmr genes by curcumin protects
the bacteria against AMPs
Intestine 407 cells, derived from embryonic intestinal cells are
rich producers of AMPs. To account for the improved survival of
curcumin-treated S. Typhimurium in these cells (Figure 1), the
sensitivity of the bacteria to AMPs (polymyxin B and protamine)
was evaluated by CFU and flow cytometry. AMP attack leads to
change in membrane permeability. This change in membrane
permeability was quantified using a fluorescent, membrane
potential sensitive dye, DiBAC4 (3). Curcumin-treated S. Typhi-
murium showed greater survival on AMP treatment (Figure 5 A &
B) and exhibited greater membrane integrity as demonstrated by
the decreased uptake of DiBAC4 (3) (Figure 5C).
S. Typhimurium protects itself from AMPs via different
mechanisms, one of them being the modification of LPS residues
reducing the net negative charge on the cell surface [43]. PmrAB
and PhoPQ regulatory system sense specific environmental cues
(low pH, low Mg
2+, high Fe
3+) and upregulate the genes involved
in LPS modification like pmrD, pmrHM, pmrE, pmrC, cld. [15,43].
High iron (Fe
3+) activates PmrAB which in turn upregulates
pmrHM and pmrE. The iron chelation caused by curcumin should
lead to down-regulation of pmrHM, pmrC etc. The promoters of
pmrD and pmrHM were cloned upstream of the promoterless lacZ
gene in pHG86 plasmid. S. Typhimurium harboring pmrD and
pmrHM-lacZ constructs were used to evaluate the change in
promoter activity of these genes on curcumin treatment. We
surprisingly found that curcumin increased the promoter activity
of pmrD and pmrHM operon (Figure 6A). Hence, we hypothesized
that curcumin might regulate pmrD and pmrHM through PhoPQ
and not through PmrAB. The pmrD and pmrHM-lacZ fusions were
transformed into phoP
- strain and the promoter activity of
respective genes was analysed on curcumin treatment. We found
that curcumin failed to increase the promoter activity of pmrD and
pmrHM in phoP
- (Figure 6A) bacteria. It did not alter the
susceptibility of phoP
- to polymyxinB nor did it improve the
survival of phoP
- in Intestine 407 cells (Figure 6B) indicating that
curcumin might regulate the expression of pmr genes through
PhoPQ. The increased expression of pmrD and pmrHM may be the
reason for the improved resistant (through LPS modification) of
curcumin treated-bacteria against polymyxinB.
Down-regulation of SPI1 genes by curcumin leads to
reduced entry of S. Typhimurium into the epithelial cells
Even though curcumin treatment increased the pathogenicity of
S. Typhimurium, the treated-bacteria were defective in entry into
the host cells in vitro (Figure 7A). This defect in entry could be due
to downregulation of SPI1 genes required for entry into non-
phagocytic host cells. HilA is a master regulator of SPI1 genes like
sipB, sipC, sopD, sopB etc. (24). hilA is also required by the bacteria
to colonize in the extracellular luminal compartment of the
intestine [44].S. Typhimurium harboring hilA and sopD-lacZ
fusions were constructed as described previously [20]. The change
in promoter activity of these genes on curcumin treatment was
examined by b-galactosidase assay. Curcumin indeed decreased
the promoter activity of the SPI1 genes tested.Thus the defect in
invasion could be ascribed to the down-regulation of SPI1 genes
(hilA and sopD) by curcumin (Figure 7C & D). Down-regulation of
hilA should result in reduced bacterial load in the small intestinal
epithelia. Nevertheless, to our surprise we found that, 1 h post-
intragastric infection, the bacterial load was high in the PP (small
intestine) of the mice infected with curcumin-treated S. Typhi-
murium (Figure 7B).
Bacteria face a myriad of environmental stress during their
passage through the gastrointestinal tract to reach the intestine,
where they invade the M cells and epithelia of the small intestine.
In the intestine within the mucus, they encounter a plethora of
antimicrobial agents. Hence, the survival efficacy of curcumin
treated-bacteria was tested in the mucus isolated from the small
intestine of mice. The treated-bacteria showed higher survival in
Figure 4. Regulation of antioxidant genes by curcumin to improve resistance of bacteria against oxidative stress. Survival of S.
Typhimurium grown in presence or absence of curcumin (20 mM) and iron (32 mg/ml FeCl3 or 20 mM FeSO4) against1 mM H2O2 (A, D) or NaNO2 (B,
E). C. Effect of curcumin on the transcriptional activities of mntH, sitA, sodA genes. b-galactosidase assay was performed 6 h post-incubation of S.
Typhimurium harboring either sitA or sodA-lacZ construct in presence or absence of curcumin (20 mM) and iron (32 mg/ml FeCl3 or 20 mM FeSO4)
in LB. F&G .Intracellular proliferation of curcumin treated and untreated bacteria in RAW 264.7 and NRAMP
+/+ BMDM respectively. *** P,0.001,
** 0.001#P,0.01 and * 0.01#P,0.05. UT- untreated, C- curcumin treated, DsitA – sitA knockout and sitA
c – sitA complement in DsitA.
doi:10.1371/journal.pone.0011511.g004
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agents could lead to increased number of bacteria reaching the
intestinal epithelia and invading it.
Thus, curcumin enhances the pathogenicity of S. Typhimurium
by increasing its resistance against different immune components.
Discussion
The intracellular survival assay demonstrated that curcumin
treatment improved the pathogenicity of S. Typhimurium. The
ability of S. Typhimurium to survive the oxidative stress inside the
SCV determines the progression of disease [23,29]. SPI2 genes
play a very important role in determining this progression [45]. It
interferes with the cellular functions and the innate immune
components of the host. The increased activity of SPI2 genes in
curcumin treated bacteria during the initial 4–5 h might accelerate
the progression of disease. The improved pathogenicity of
curcumin-treated S. Typhimurium can also be ascribed to its
increased resistance against the damaging effects of the oxidative
congeners, H2O2 and NO
., and AMPs (polymyxin B and
protamine).
S. Typhimurium harbors quite a few mechanisms to counteract
oxidative stress. One such mechanism is through the acquisition of
Mn
2+ ions. Horsburgh et al. demonstrated that accumulation of
manganese in the bacterial cell catalytically detoxifies reactive
oxygen species and protects the bacteria from the oxidative
damage [46]. It is known that mutants of sitABCD and mntH are
attenuated for the survival within the host [35,37,47] and are
required for full virulence especially in NRAMP1
+/+ mice [38]. S.
Typhimurium also has SodA which is important for resistance
Figure 5. Sensitivity of S. Typhimurium to antimicrobial peptides. Survival of S. Typhimurium grown in presence (C) or absence (UT) of
curcumin (20 mM) and iron (32 mg/ml FeCl3 or 20 mM FeSO4) against A. Polymyxin B (1 mg/ml) and B. Protamine (50 mg/ml). C. Membrane potential
assay. The polymyxinB or protamine treated S. Typhimurium were stained with DiBAC4 (3) and analysed in FACS scanner.
doi:10.1371/journal.pone.0011511.g005
Figure 6. Regulation of pmr genes by curcumin to improve resistance of bacteria against AMPs. A. Effect of curcumin on the
transcriptional activities of pmrD and pmrHFIJKLM genes. b-galactosidase assay was performed 3 h post-incubation of S. Typhimurium harboring
either pmrD or pmrHFIJKLM -lacZ construct in presence or absence of curcumin (20 mM) and iron (32 mg/ml FeCl3 or 20 mM FeSO4) in LB. B.
Susceptibilty of phoP
- strain to polymyxin B. C. Intracellular survival assay of phoP
- strain in Intestine 407 cells. The Intestine 407 cells infected with
solvent (S), curcumin (C, 20 mM) treated or untreated (UT) S. Typhimurium were lysed at 2 h & 16 h post infection and fold replication of the bacteria
was calculated. *** P,0.001, ** 0.001#P,0.01 and * 0.01#P,0.05.
doi:10.1371/journal.pone.0011511.g006
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protection against oxidative stress under iron limiting conditions
[39]. Our work demonstrate that curcumin increase the expression
of sitA, mntH and sodA conferring protection against oxidative
stress. Curcumin also downregulates hilA which correlates well
with the findings of Ellermeier et al. where they show that addition
of metal chelator 2,2-dipyridyl to the growth medium increase the
expression of sitA and decrease the expression of hilA [48]. It is also
known that sitA and mntH are regulated by iron concentration [14]
and cation chelators [36,49]. As curcumin acts as an iron chelator
Figure 7. Curcumin treated bacteria show reduced entry in-vitro but not in-vivo. A. The entry of curcumin (C, 20 mM) treated and
untreated (UT) S. Typhimurium in Intestine 407 cells. The entry in Intestine 407 cells was determined by lysing the infected cells 30 min post-infection.
B. CFU per gram weight of Peyer’s patch of mice infected intragastrically with curcumin-treated and untreated S. Typhimurium. 1 h post-infection
Peyer’s patch were aseptically isolated, processed to get CFU/gm. C. Effect of curcumin on the transcriptional activity of hilA and sopD promoter. b-
galactosidase activity was performed using S. Typhimurium harboring either hilA or sopD -lacZ construct grown in presence or absence of curcumin
to know the transcriptional activity. D. RT-PCR analysis to check the expression of hilA in curcumin-treated and untreated S. Typhimurium. RT-PCR
with the mRNA isolated from curcumin treated and untreated S. Typhimurium was performed. E. Percentage survival of bacteria in the mucus from
small intestine of mice. Curcumin-treated and untreated bacteria were inoculated in the mucus for 1 h and their survival calculated. *** P,0.001 and
* 0.01#P,0.05.
doi:10.1371/journal.pone.0011511.g007
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may modulate the expression of the genes, sitA and mntH,
protecting the bacteria from oxidative stress, and hilA, hindering
its entry into epithelial cells. Iron chelators are known to govern
the expression of phoP and other SPI2 genes [47]. The regulation
of SPI2 genes (atleast spiC and sseB) by curcumin could also be
explained through the iron chelation property of curcumin.
Zaharik et al. showed that depletion of Fe
2+ and Mn
2+ in SCV
causes up-regulation of mntH and sitA. Martin-Orozco et al.
demonstrated that NRAMP1 has no effect on PhoP induction and
the bacteriostatic/cidal effect of NRAMP1 is independent of
PhoPQ. Our result show that curcumin has no effect on
intracellular proliferation of DphoP in RAW 264.7 cells but
increases its proliferation in NRAMP1
+/+ cells, as compared to
untreated bacteria. Curcumin does not alter the proliferation of
DsitA in both RAW 264.7 cells and NRAMP
+/+ BMDM. This
suggests that the action of curcumin on sitA is also important for
the survival of bacteria especially in NRAMP1
+/+ cells.
The ability of curcumin to scavenge free radicals might also
offer protection against oxidative stress [50]. Curcumin was found
to be incorporated into S.Typhimurium (Materials and Methods
S1, 50 to 75 mg/gm of bacterial dry mass, Supplementary Figure
S3, Previous report suggest that iron chelators that penetrate
bacteria (dipyridyl, o-phenanthroline, and desferrioxamine) can
protect the DNA from damage by exogenous H2O2 [51].
Similarly, curcumin that enters the cell might also protect the
bacteria against the oxidative stress.
Salmonella counteracts the effect of AMPs either by LPS
modification or secretion of some proteases [43]. PhoPQ and
PmrAB regulate the LPS modifying system. These two-component
regulatory systems are activated by different environmental cues.
Upon activation, PhoPQ increases the transcription of pmrD whose
protein product stabilizes activated PmrA which in turn activates
the genes involved in LPS modification, e.g. pmrHM, pmrE etc (22).
PmrA is also activated independently by high Fe
3+/Al
3+, low pH
etc. [15]. Iron chelation caused by curcumin should lead to down-
regulation of PmrAB system and hence pmrHM, pmrE etc.
However, we found that in presence of curcumin pmrD and
pmrHM are upregulated.
Curcumin has been shown to modify the function of membrane
proteins by changing the lipid bilayer properties [52]. In a similar
way, curcumin might modulate the function of PhoQ, a
membrane bound sensor kinase that is activated upon conforma-
tional change [53], further leading to the enhanced transcription
of pmrD and hence the activation of LPS modifying system. Iron
chelators increase the expression of phoP [47]. Iron chelation by
curcumin might also contribute to the above phenomena. Further
study needs to be done to elucidate the exact mechanism by which
curcumin might regulate PhoPQ system. It is also known that
activation of PhoPQ leads to the down-regulation of hilA and other
Figure 8. Schematic summary representing the mode of action of curcumin. Iron chelation caused by curcumin might increase the
expression of different genes involved in defense of S. Typhimurium against host immune response.
doi:10.1371/journal.pone.0011511.g008
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regulation of hilA by curcumin.
Curcumin-treated WT bacteria but not DphoP (data not shown)
are defective in entry into the epithelial cells under in vitro
condition. However, 1 h post-intragastric infection, higher num-
bers of bacteria were found in PP of mice infected with curcumin
treated bacteria. The resistance offered by curcumin against
different antimicrobial agents might benefit the bacteria when
inside intestinal lumen where it encounters hoard of antimicrobi-
als. This may result in increased number of bacteria crossing the
mucus barrier and invading the M-cells in PP. Further, the
bacterial load was high in the different organs of the mice infected
(intragastrically or intraperitoneally) with curcumin treated S.
Typhimurium. This corroborates with the observations that
curcumin protects S. Typhimurium against the innate immune
components of the host viz. ROS, RNI and AMPs that the
bacteria encounter in the intestinal lumen, macrophages and
neutrophils that disseminate them to different systemic organs.
The schematic summary for the possible mode of action of
curcumin is given in Figure 8.
Curcumin treated Salmonella enterica serovar Typhi also shows
higher fold proliferation in Intestine 407 and RAW 264.7 cell-lines
(Supplementary Figure S4). Treatment of RAW 264.7 cells with
curcumin (20 mM) also lead to increased intracellular proliferation
of S. Typhimurium (S. A. Marathe and D. Chakravortty,
unpublished data) indicating that treatment of either pathogen
or host with curcumin enhances its pathogenicity.
Turmeric is widely used as a therapeutic as well as a food
ingredient especially in Asia [1]. Certain Southeast Asian
communities consume 1.5 g/person/day of turmeric that corre-
sponds to 0.03–0.12 g of curcumin/person/day [1]. According to
Centers for Disease Control and Prevention, the prevalence of
Salmonella infection is more in Asia, Africa and Latin America. In
addition, the prevalence of typhoid is highest in Asia. Of 2,16,000
deaths due to typhoid in the year 2000, more than 90% of
morbidity and mortality occurred in Asia [57].We hypothesize
that the high consumption of curcumin could be one of the reason
for the widespread occurrence of Salmonella infections in Asian
countries (especially in Southeast Asia). Even though curcumin has
protective action against cancer [1,42] and H.pylori infections [58]
it should be consumed with a caution especially during the
outbreak of Salmonella infections and in the endemic areas.
Curcumin is not a panacea for all! Our data is the first of its
kind which suggest that the curcumin can increase the pathoge-
nicity of Salmonella by making it more robust. Hence, during
Salmonella infection, the consumption of curcumin should be
avoided.
Supporting Information
Figure S1 Cytotoxicity of curcumin. A. MTT test for cytotox-
icity in RAW 264.7, Intestine 407 and Caco-2 cells after 24 h of
curcumin (20 mM) treatment. B. Growth curve in LB media: The
growth pattern of S. Typhimurium was checked in presence or
absence of curcumin (20 M).
Found at: doi:10.1371/journal.pone.0011511.s001 (0.07 MB
TIF)
Figure S2 Growth curve of S. Typhimurium in F-media. S.
Typhimurium grown overnight in LB, either in presence (C,
20 mM) or absence of curcumin (UT) was subcultured in F-media,
pH 5, incubated at 37uC under shaking conditions and the OD
measured at 600 nm at different time points and plotted.
Found at: doi:10.1371/journal.pone.0011511.s002 (0.03 MB TIF)
Figure S3 Incorporation of curcumin in S. Typhimurium. S.
Typhimurium grown in presence or absence of curcumin (C,
20 mM) was pelleted and then washed twice with PBS. The pellet
was dried and weighed. The dried pellet was resuspended in
DMSO to dissolve curcumin present, if any. The Absorbance of
the solution was taken at 420 nm. The weight of curcumin per
gram weight of bacterial dry pellet was analysed.
Found at: doi:10.1371/journal.pone.0011511.s003 (0.04 MB TIF)
Figure S4 Fold proliferation of S. Typhi. The cells (RAW 264.7
and Intestine 407) infected with curcumin (C, 20 mM) treated and
untreated (UT) S. Typhimurium were lysed at 2 h & 16 h post
infection. The fold replication of the bacteria from 2 h to 16 h was
calculated.
Found at: doi:10.1371/journal.pone.0011511.s004 (0.05 MB TIF)
Table S1 Primers used in this study.
Found at: doi:10.1371/journal.pone.0011511.s005 (0.04 MB
DOC)
Materials and Methods S1 Supplementary materials and
methods.
Found at: doi:10.1371/journal.pone.0011511.s006 (0.02 MB
DOC)
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